News | September 14, 2021
Bill Haney adds another $133M to Skyhawk’s coffers, as the RNA startup guns for the clinic
Read More
Press Release | September 14, 2021
Skyhawk Therapeutics Completes New Investment Round
Read More
Press Release | September 8, 2021
Immunitas Therapeutics Appoints Seng-Lai ‘Thomas’ Tan, Ph.D. as Chief Scientific Officer
Read More
Press Release | August 18, 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Read More
